1. Home
  2. PHAT vs SLI Comparison

PHAT vs SLI Comparison

Compare PHAT & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

N/A

Current Price

$5.22

Market Cap

590.6M

Sector

Health Care

ML Signal

N/A

Logo Standard Lithium Ltd.

SLI

Standard Lithium Ltd.

N/A

Current Price

$1.47

Market Cap

524.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PHAT
SLI
Founded
2018
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
590.6M
524.3M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
PHAT
SLI
Price
$5.22
$1.47
Analyst Decision
Strong Buy
Buy
Analyst Count
11
6
Target Price
★ $20.05
$4.49
AVG Volume (30 Days)
★ 1.8M
1.7M
Earning Date
10-29-2026
08-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 42.72
N/A
EPS
N/A
★ N/A
Revenue
★ $175,110,000.00
N/A
Revenue This Year
$79.63
N/A
Revenue Next Year
$54.71
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 216.93
N/A
52 Week Low
$5.02
$1.32
52 Week High
$18.31
$6.00

Technical Indicators

Market Signals
Indicator
PHAT
SLI
Relative Strength Index (RSI) 30.97 42.68
Support Level $5.02 $1.32
Resistance Level $11.85 $1.58
Average True Range (ATR) 0.62 0.09
MACD -0.08 0.02
Stochastic Oscillator 7.10 50.00

Price Performance

Historical Comparison
PHAT
SLI

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.

Share on Social Networks: